Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 31, 2009, Pages 12926-12931

  Eisele, Yvonne S ^a,b   Bolmont, Tristan ^a   Heikenwalder, Mathias ^c   Langer, Franziska ^a,b   Jacobson, Laura H ^d   Yan, Zheng Xin ^e   Roth, Klaus ^e   Aguzzi, Adriano ^c   Staufenbiel, Matthias ^d   Walker, Lary C ^f   Jucker, Mathias ^a,g  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NOVARTIS PHARMA AG   (Switzerland)

^e SMP GmbH   (Germany)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Alzheimer's disease; Amyloid; Prion; Sterilization; Transmission

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN EXTRACT; STAINLESS STEEL;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HOST; IMPLANT; INOCULATION; INSTRUMENT STERILIZATION; MALE; MOUSE; NONHUMAN; OLFACTORY BULB; PARIETAL LOBE; PLASMA; PRION; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; BRAIN DISEASE; C57BL MOUSE; COMPARATIVE STUDY; METABOLISM; PRION DISEASE;

MUS MUSCULUS;

AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANIMALS; BRAIN DISEASES; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRION DISEASES;

EID: 69149098707     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0903200106     Document Type: Article

References (44)

1. Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426:900-904.
2. Castilla J, et al. (2008) Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134:757-768.
3. Legname G, et al. (2004) Synthetic mammalian prions. Science 305:673-676.
4. Aguzzi A, Sigurdson C, Heikenwalder M (2008) Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 3:11-40.
5. Collinge J, Clarke AR (2007) A general model of prion strains and their pathogenicity. Science 318:930-936.
6. Prusiner SB (2004) Prion Biology and Diseases (Cold Spring Harbor Lab Press, Cold Spring Harbor, NY), 2nd Ed.
7. Legname G, et al. (2006) Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 103:19105-19110.
8. Walker LC, Levine H, 3rd, Mattson MP, Jucker M (2006) Inducible proteopathies. Trends Neurosci 29:438-443.
9. Westermark P, Westermark GT (2008) Review: Reflections on amyloidosis in Papua New Guinea. Philos Trans R Soc London B 363:3701-3705.
10. Kane MD, et al. (2000) Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J Neurosci 20:3606-3611.
11. Meyer-Lühmann M, et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781-1784.
12. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ (1994) Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate: Comparison with transmission of spongiform encephalopathy. Mol Neurobiol 8:25-39.
13. Ridley RM, Baker HF, Windle CP, Cummings RM (2006) Very-long-term studies of the seeding of beta-amyloidosis in primates. J Neural Transm 113:1243-1251.
14. Riek R (2006) Cell biology: Infectious Alzheimer's disease? Nature 444:429-431.
15. Walker L, Levine H, Jucker M (2006) Koch's postulates and infectious proteins. Acta Neuropathol 112:1-4.
16. Mabbott NA, MacPherson GG (2006) Prions and their lethal journey to the brain. Nat Rev Microbiol 4:201-211.
17. Blattler T, et al. (1997) PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389:69-73.
18. Bernoulli C, et al. (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet i(8009):478-479.
19. Gibbs CJ, Jr, et al. (1994) Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 57:757-758.
20. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C (1999) Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5:240-243.
21. Flechsig E, et al. (2001) Transmission of scrapie by steel-surface-bound prions. Mol Med 7:679-684.
22. Sturchler-Pierrat C, et al. (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287-13292.
23. Calhoun ME, et al. (1998) Neuron loss in APP transgenic mice. Nature 395:755-756.
24. Selkoe DJ, Schenk D (2003) Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43:545-584.
25. Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H (2006) The development of amyloid beta protein deposits in the aged brain. Sci Aging Knowledge Environ 2006:re1.
26. Weller RO, Djuanda E, Yow HY, Carare RO (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117:1-14.
27. McKintosh E, Tabrizi SJ, Collinge J (2003) Prion diseases. J Neurovirol 9:183-193.
28. Belay ED, Schonberger LB (2005) The public health impact of prion diseases. Annu Rev Public Health 26:191-212.
29. Turner ML, Ludlam CA (2009) An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol 144:14-23.
30. Wadsworth JD, Collinge J (2007) Update onhumanprion disease. Biochim Biophys Acta 1772:598-609.
31. Aguzzi A, Sigurdson CJ (2004) Antiprion immunotherapy: To suppress or to stimulate? Nat Rev Immunol 4:725-736.
32. Sbriccoli M, et al. (2009) Neuroinvasion of the 263K scrapie strain after intranasal administration occurs through olfactory-unrelated pathways. Acta Neuropathol 117:175-184.
33. Bartz JC, Kincaid AE, Bessen RA (2003) Rapid prion neuroinvasion following tongue infection. J Virol 77:583-591.
34. Kincaid AE, Bartz JC (2007) The nasal cavity is a route for prion infection in hamsters. J Virol 81:4482-4491.
35. Brandner S, et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339-343.
36. Brandner S, et al. (1996) Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci USA 93:13148-13151.
37. Shimazawa M, et al. (2008) Reduced retinal function in amyloid precursor protein-overexpressing transgenic mice via attenuating glutamate-N-methyl- D-aspartate receptor signaling. J Neurochem 107:279-290.
38. Ning A, Cui J, To E, Ashe KH, Matsubara J (2008) Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci 49:5136-5143.
39. Johan K, et al. (1998) Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 95:2558-2563.
40. Lundmark K, Westermark GT, Olsen A, Westermark P (2005) Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism. Proc Natl Acad Sci USA 102:6098-6102.
41. Fu X, et al. (2004) Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett 563:179-184.
42. Yan ZX, Stitz L, Heeg P, Pfaff E, Roth K (2004) Infectivity of prion protein bound to stainless steel wires: A model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 25:280-283.
43. Herzig MC, et al. (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7:954-960.
44. Stalder AK, et al. (2005) Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci 25:11125-11132.